Predicting Cardiometabolic Risk in Mild-to-Moderate Obstructive Sleep Apnea: Inflammation vs. Apnea/Hypopnea Index
| Status: | Enrolling by invitation |
|---|---|
| Conditions: | Insomnia Sleep Studies, Pulmonary, Pulmonary |
| Therapuetic Areas: | Psychiatry / Psychology, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 1/5/2019 |
| Start Date: | March 1, 2017 |
| End Date: | December 2019 |
The purpose of the study is to compare the relative contribution of systemic inflammation vs.
Obstructive Sleep Apnea (OSA) severity (as measured by Apnea Hypopnea Index) in predicting
cardiovascular and metabolic aberrations associated with mild-to-moderate obstructive sleep
apnea.
Obstructive Sleep Apnea (OSA) severity (as measured by Apnea Hypopnea Index) in predicting
cardiovascular and metabolic aberrations associated with mild-to-moderate obstructive sleep
apnea.
Inclusion Criteria:
- Mild to moderate OSA (5≤ AHI <30)
- BMI ≤ 45
- Age ≥ 18
- Men & Women
Exclusion Criteria:
- AHI ≥ 30
- BMI >45
- Current use of steroids or anti-inflammatory medication
- Diagnosis of insulin dependent diabetes
- Diagnosis of autoimmune disorder
- Shiftwork
- Current use of CPAP
We found this trial at
1
site
Hershey, Pennsylvania 17033
Click here to add this to my saved trials
